RxDoctor Payments Data

Michael Perri, PA

Physician Assistant · Tifton, GANPI 1235252792

Payments from drug & device makers

$489in general payments, 2019–2025

Across 30 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$218
  • GSK$158
  • Dexcom, Inc.$45
  • Astellas Pharma US Inc$24
  • Exact Sciences$16
  • Amgen$15
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$489100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$489 in reported general payments places this provider in the 55th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$35,029
Medicare patients
207
Services billed
601

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide179$270,895
OzempicSemaglutide160$187,410
EliquisApixaban167$140,332
TrulicityDulaglutide50$83,045
XareltoRivaroxaban58$45,828
FarxigaDapagliflozin Propanediol39$45,757
LinzessLinaclotide46$39,894
MyrbetriqMirabegron46$28,813
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/726$26,958
Spiriva RespimatTiotropium Bromide38$26,371
JanuviaSitagliptin Phosphate29$25,773
JardianceEmpagliflozin15$18,034
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt20$17,597
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$11,932
Lantus SolostarInsulin Glargine,hum.Rec.Anlog67$10,835

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$218$190,880172 claims
Astellas Pharma US IncMyrbetriq$24$28,81346 claims
GSKTrelegy Ellipta$158$11,93216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Tifton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →